M. L. Clements-Mann

发表

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults.

I. M. Gonzalez, R. Karron, M. Eichelberger, 2000, Vaccine.

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

S S Whitehead, R. Karron, B. Murphy, 1997, Proceedings of the National Academy of Sciences of the United States of America.

A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant.

M. L. Clements-Mann, R. Jacobson, G. Poland, 1999, Vaccine.

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.

M. L. Clements-Mann, D. Montefiori, M. McElrath, 1999, The Journal of infectious diseases.

Immunogenicity of two doses of yeast recombinant hepatitis B vaccine in healthy older adults.

M. L. Clements-Mann, B. Gellin, J. Bertino, 1997, The Journal of infectious diseases.

Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants.

R. Karron, M. L. Clements-Mann, J. Mrukowicz, 1999, Vaccine.

Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants.

R. Karron, M. L. Clements-Mann, A. Kapikian, 2001, Vaccine.

Lessons for AIDS vaccine development from non-AIDS vaccines.

M. L. Clements-Mann, 1998, AIDS research and human retroviruses.

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group.

R. Siliciano, E. Paoletti, J. Mascola, 1998, The Journal of infectious diseases.

Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.

R. Karron, B. Murphy, M. L. Clements-Mann, 1997, The Journal of infectious diseases.

Clinical evaluation of a single oral dose of human‐bovine (UK) reassortant rotavirus vaccines Wa x UK (P1A[8],G6) and Wa x (DS‐1 x UK) (P1A[8],G2)

R. Karron, M. Eichelberger, M. L. Clements-Mann, 2002, Journal of medical virology.

Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.

M. L. Clements-Mann, D. Montefiori, D. Stablein, 2001, The Journal of infectious diseases.

Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group.

M. L. Clements-Mann, R. Belshe, B. Graham, 1997, AIDS research and human retroviruses.